Evidence map›Paper›PMID 29675647›Full record

ArticleJournal of materials science. Materials in medicine2018

Fabrication of agarose concave petridish for 3D-culture microarray method for spheroids formation of hepatic cells.

Binbin Zhang, Yang Li, Gaoshang Wang, Zhidong Jia, Haiyan Li, Qing Peng, Yi Gao

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of materials science. Materials in medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Binbin ZhangDepartment of Hepatobiliary Surgery II,Guangdong Provincial Research Center for Artificial Organ and Tissue Engineering, Guangzhou Clinical Research and Transformation Center for Artificial Liver, Institute of Regenerative Medicine, Zhujiang Hospital of Southern Medical University, Guangzhou, 510000, Guangdong Province, China.
Yang LiDepartment of Hepatobiliary Surgery II,Guangdong Provincial Research Center for Artificial Organ and Tissue Engineering, Guangzhou Clinical Research and Transformation Center for Artificial Liver, Institute of Regenerative Medicine, Zhujiang Hospital of Southern Medical University, Guangzhou, 510000, Guangdong Province, China.
Gaoshang WangDepartment of Hepatobiliary Surgery II,Guangdong Provincial Research Center for Artificial Organ and Tissue Engineering, Guangzhou Clinical Research and Transformation Center for Artificial Liver, Institute of Regenerative Medicine, Zhujiang Hospital of Southern Medical University, Guangzhou, 510000, Guangdong Province, China.
Zhidong JiaDepartment of Hepatobiliary Surgery II,Guangdong Provincial Research Center for Artificial Organ and Tissue Engineering, Guangzhou Clinical Research and Transformation Center for Artificial Liver, Institute of Regenerative Medicine, Zhujiang Hospital of Southern Medical University, Guangzhou, 510000, Guangdong Province, China.
Haiyan LiDepartment of Hepatobiliary Surgery II,Guangdong Provincial Research Center for Artificial Organ and Tissue Engineering, Guangzhou Clinical Research and Transformation Center for Artificial Liver, Institute of Regenerative Medicine, Zhujiang Hospital of Southern Medical University, Guangzhou, 510000, Guangdong Province, China.
Qing PengDepartment of Hepatobiliary Surgery II,Guangdong Provincial Research Center for Artificial Organ and Tissue Engineering, Guangzhou Clinical Research and Transformation Center for Artificial Liver, Institute of Regenerative Medicine, Zhujiang Hospital of Southern Medical University, Guangzhou, 510000, Guangdong Province, China. zhujiangzhuanhua@163.com.
Yi GaoDepartment of Hepatobiliary Surgery II,Guangdong Provincial Research Center for Artificial Organ and Tissue Engineering, Guangzhou Clinical Research and Transformation Center for Artificial Liver, Institute of Regenerative Medicine, Zhujiang Hospital of Southern Medical University, Guangzhou, 510000, Guangdong Province, China. gaoyi6146@163.com.ORCID http://orcid.org/0000-0002-4536-6191
Zhujiang Hospital · CNShantou University · CN

Funding

Science and Technology Development Cultivation Project of Southern Medical University C1033042Science and Technology Planning Project of Guangdong Province 2014B020227002Science and Technology Planning Project of Guangdong Province 2015B020229002Science and Technology Planning Project of Guangdong Province 2015B090903069Science and Technology Program of Guangzhou 201604020002the National Natural Science Foundation of China (81470875) 81470875The Natural Science Foundation of Guangdong Province 2014A030312013
6 · The paper itself

Abstract

Liver is one of the most important organ in the body. But there are many limitations about liver transplantation for liver failure. It is quite important to develop the xenogeneic biological liver for providing an alternation to transplantation or liver regeneration. In this paper, we proposed a method to construct a novel kind of agarose 3D-culture concave microwell array for spheroids formation of hepatic cells. Using the 3D printing method, the microwell array was fabricated with an overall size of 6.4 mm × 6.4 mm, containing 121 microwells with 400 μm width/400 μm thickness. By exploiting the Polydimethylsiloxane (PDMS) membranes as a bridge, we finally fabricated the agarose one. We co-cultured three types of liver cells with bionics design in the microwell arrays. Using the methods described above, the resulting co-formed hepatocyte spheroids maintained the high viability and stable liver-specific functions. This engineered agarose concave microwell array could be a potentially useful tool for forming the elements for biological liver support. After developing the complete system, we also would consider to scale up the application of this system. It will be not only applied to the therapy of human organ damage, but also to the development of disease models and drug screening models.

Indexed as

Cell Culture TechniquesCells, CulturedCoculture TechniquesDimethylpolysiloxanesHepatocytesHumansLiverMembranes, ArtificialMicrotechnologySepharoseSpheroids, CellularTissue Array AnalysisbaysilonDimethylpolysiloxanesMembranes, ArtificialSepharose

Identifiers

PMID29675647
OpenAlexW2801714940

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.